Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Recurrence
×
idecabtagene vicleucel
×
Clear all
Filters
3
NCT03601078
2026-03-04
KarMMa-2
Celgene
Phase 2
Completed
312 enrolled
NCT03361748
2025-05-23
KarMMa
Celgene
Phase 2
Completed
149 enrolled
29 charts
1 FDA